Epidemiological profile of COVID-19 in indigenous communities in the state of Alagoas, Brazil
DOI:
https://doi.org/10.47456/rbps.v23i1.34250Keywords:
Epidemiology, Coronavirus infections, Indigenous peoplesAbstract
Introduction: The pandemic of COVID-19 revealed the scenario of inequalities experienced by the indigenous population, subjected to social determinants in health that make them more susceptible to suffer a disproportionate impact from the disease. Objectives: To describe the epidemiological profile of COVID-19 in indigenous communities in the state of Alagoas-BR. Methods: Ecological, descriptive study, based on reports published by the State Health Secretariat of Alagoas, with the inclusion of data until 01/29/2021. The frequency of confirmed cases, accumulated deaths and the lethality rate according to ethnicity, sex and age group were investigated. The data were analyzed using Microsoft Office Excel®. Results:Of the 16,291 indigenous people residing in the State, 6,268 were considered to correspond to indigenous villagers. 212 confirmed cases were registered, and 5 deaths accumulated among ethnic groups. Among the confirmed cases, 32.5% were from the Xucuru-Kariri ethnic group, 54.2% were male and 74.1% were from 20 to 59 years old. There was a greater prevalence of death in males and in the age group of 20 to 59 years, with 60% in both cases. Regarding the lethality rate, the Karapotó ethnic group stood out with 9.1%, the male gender with 2.6% and the age group of 60 years old or over with 7.4%. Conclusion: Among the indigenous population of Alagoas, there was a predominance of confirmed cases and deaths in adult males, with the Xucuru-Kariri ethnic group having the largest number of confirmed cases. The lethality rate was higher in the Karapotó ethnic group and in elderly males.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
